| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 07/12/2000 | CN1259522A Novel protain from lobar pneumonia Actinomyces |
| 07/11/2000 | US6087166 Transcriptional activators with graded transactivation potential |
| 07/11/2000 | CA2082948C Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 07/11/2000 | CA1341048C Method and compositions for making acsf and acsf antagonists |
| 07/06/2000 | WO2000039299A2 Streptococcus antigens |
| 07/06/2000 | WO2000039298A1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum |
| 07/06/2000 | WO2000039278A2 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| 07/06/2000 | WO2000039157A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | WO2000020607A3 Chimaeric proteins between members of tgf-beta superfamily |
| 07/06/2000 | WO2000020591A3 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 07/06/2000 | CA2356057A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/05/2000 | EP1016723A1 Recombinant synthesis of beta-Lipotropin and other peptides |
| 07/05/2000 | EP1016716A2 Dna encoding a growth factor specific for epithelial cells |
| 07/05/2000 | EP1015593A1 Hepatitis b virus polypeptides |
| 07/05/2000 | EP1015587A1 DcR3 POLYPEPTIDE, A TNFR HOMOLOG |
| 07/05/2000 | EP1015585A2 Tie ligand homologues |
| 07/05/2000 | EP1015496A2 Immuntoxins and methods of inducing immune tolerance |
| 07/05/2000 | EP1015473A1 CLONING AND EXPRESSION OF betaAPP-C100 RECEPTOR (C100-R) |
| 07/05/2000 | EP0619839B1 Novel polypeptides for promoting cell attachment |
| 07/04/2000 | US6084088 Polynucleotides encoding novel tumor antigens |
| 07/04/2000 | US6084084 Nucleotide and amino acid sequences; for anticonvulsants, neuroprotectants, analgesics and cognition enhancers; for diagnosis and therapy of related nervous system disorders |
| 07/04/2000 | US6084083 Amino acid sequence of polypeptide; for prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of t helper cell related disorders including crohn's disease, lyme disease, insulin-dependent diabetes |
| 07/04/2000 | US6084067 CTLA4/CD28 ligands and uses therefor |
| 07/04/2000 | US6083910 Therapeutic uses of resolved intact or clipped native-sequence PDGF-BB dimers |
| 07/04/2000 | US6083723 Vector comprising regulatory nucleotide sequences and nucleic acids that code for a exogenous polypeptide |
| 07/04/2000 | US6083713 Nucleotide sequences coding binding polypeptide for the terminal domain of the amyloid precursor protein; for the diagnosis and design of drugs for treatment of alzheimer's disease |
| 07/04/2000 | US6083706 Inhibitors of leaderless protein export |
| 07/04/2000 | US6083502 Methods for detecting the antigen and its expression level as an indication of the presence of tumor cells |
| 07/04/2000 | US6083477 Useful therapeutic reagents for treating leukemias and lymphomas;conjugate of a non-immunogenic rnase or a therapeutic radionuclide that is an alpha-emitter or a beta-emitter and a cell-specific cytokine |
| 07/04/2000 | CA1341042C Y, & t cell receptor and methods for detection |
| 06/29/2000 | WO2000037643A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 06/29/2000 | WO2000037642A1 Method of enhancing the biological activity of ligands |
| 06/29/2000 | WO2000037640A2 Compositions and methods for the treatment of tumor |
| 06/29/2000 | WO2000037638A2 Methods and compositions for inhibiting neoplastic cell growth |
| 06/29/2000 | WO2000037615A1 Recombinant synthesis of beta-lipotropin and other peptides |
| 06/29/2000 | WO2000037483A1 Protein-protein interactions in neurodegenerative disorders |
| 06/29/2000 | WO2000017221A9 Method of measuring protein-protein interactions in living cells |
| 06/29/2000 | WO2000006717A3 Improved transformation efficiency in phage display through modification of a coat protein |
| 06/29/2000 | WO2000006605A3 Heterominibodies |
| 06/29/2000 | WO2000001817A3 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 06/29/2000 | WO1999003881A3 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
| 06/29/2000 | CA2450402A1 Methods and compositions for inhibiting cancer cell growth comprising pro224 |
| 06/29/2000 | CA2358086A1 Protein-protein interactions in neurodegenerative disorders |
| 06/29/2000 | CA2356987A1 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 06/29/2000 | CA2355402A1 Recombinant synthesis of beta-lipotropin and other peptides |
| 06/29/2000 | CA2354846A1 Method of enhancing the biological activity of ligands |
| 06/29/2000 | CA2353799A1 Methods and compositions for inhibiting neoplastic cell growth |
| 06/29/2000 | CA2353775A1 Compositions and methods for the treatment of tumor |
| 06/28/2000 | EP1013761A2 Humanized chimeric antibody directed against ganglioside GD3 |
| 06/28/2000 | EP1013760A2 Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same |
| 06/28/2000 | EP1012320A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 06/28/2000 | EP1012312A1 Mosaic protein and restriction endonuclease assisted ligation method for making the same |
| 06/28/2000 | EP1012310A1 Fusion proteins comprising coiled-coil structures |
| 06/28/2000 | EP1012308A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 06/28/2000 | EP1012293A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 06/28/2000 | EP1012292A1 Ntn-2 member of tnf ligand family |
| 06/28/2000 | EP1012283A1 Mage-3 peptides presented by hla class ii molecules |
| 06/28/2000 | EP1012282A1 Cysteine rich receptors-train |
| 06/28/2000 | EP1012256A2 Recombinant fusion proteins based on ribosome-inactivating proteins of european mistletoe viscum album |
| 06/28/2000 | EP1012248A1 Novel thermophilic polymerase iii holoenzyme |
| 06/28/2000 | EP1011655A1 Inhibitors of leaderless protein export |
| 06/28/2000 | EP0639224B1 Lectin domain variants of selectin |
| 06/28/2000 | CN1258315A Mammalian cytokine-like factor-7 |
| 06/28/2000 | CN1053964C Immunochemical detection of in vivo advanced glycosylation endproducts |
| 06/27/2000 | CA2089553C Multidomain hematopoiesis stimulators |
| 06/23/2000 | CA2256124A1 Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans |
| 06/22/2000 | WO2000036129A1 Enhanced protein production in higher plants by n-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
| 06/22/2000 | WO2000036118A2 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE) |
| 06/22/2000 | WO2000036107A2 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 06/22/2000 | WO2000036105A1 Prostacyclin-stimulating factor-2 |
| 06/22/2000 | WO2000036104A1 Pancreatic polypeptide zsig66 |
| 06/22/2000 | WO2000036103A1 Cytokine receptor chain |
| 06/22/2000 | WO2000036102A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/22/2000 | WO2000036092A2 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 06/22/2000 | WO2000035949A1 Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation |
| 06/22/2000 | WO2000035946A1 Methods |
| 06/22/2000 | WO2000035481A2 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| 06/22/2000 | WO2000023955A8 Virus-like particles for the induction of autoantibodies |
| 06/22/2000 | WO2000012544A3 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor |
| 06/22/2000 | WO2000011033A3 Expression and export of angiostatin and endostatin as immunofusins |
| 06/22/2000 | WO1999059615A9 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 06/22/2000 | CA2355363A1 Prostacyclin-stimulating factor-2 |
| 06/22/2000 | CA2355270A1 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| 06/22/2000 | CA2355039A1 Pancreatic polypeptide zsig66 |
| 06/22/2000 | CA2354539A1 A method for the high level expression of active lymphotoxin-.beta. receptor immunoglobulin chimeric proteins and their purification |
| 06/22/2000 | CA2354156A1 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 06/21/2000 | EP1009847A1 Conjugates that contain the homeodomain of antennapedia |
| 06/21/2000 | EP1009834A1 Regulation of protein secretion |
| 06/21/2000 | EP1009832A1 Cytokine designated lerk-6 |
| 06/21/2000 | EP1009831A2 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 06/21/2000 | EP1009826A1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof |
| 06/21/2000 | EP1009817A1 Rtd receptor |
| 06/21/2000 | EP1009814A1 Human receptor tyrosine kinase, kdr |
| 06/21/2000 | EP1009761A1 Biomolecules comprising an elastomeric peptide |
| 06/21/2000 | DE19916224C1 Synthetic molecule for delivering active ingredient to cell, used e.g. to treat human immune deficiency virus infection, comprises the ingredient linked to VP2 or 3 peptide from polyoma virus |
| 06/21/2000 | CN1257545A Type II TGF-beta receptor/immunoglobulin constant region fusion proteins |
| 06/21/2000 | CN1257543A Human prohormone convertase 4 |
| 06/21/2000 | CN1053699C Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 06/20/2000 | US6077835 Administering composition comprising compacted, unaggregated nucleic acid complexes, each complex consisting essentially of a single nucleic molecule encoding a protein and one or more carrier molecules to facilitate their uptake by target cells |
| 06/20/2000 | US6077675 Drug screening by contacting compound with recombinant cell which expresses a nucleic acid encoding the receptor and monitoring for binding or modulation of receptor; anticonvulsants; analgesics; cognition enhancers |